Exponent, Inc. (NASDAQ: EXPO) reported Q1 EPS of $0.75, $0.04 better than the analyst estimate of $0.71. Revenue for the quarter came in at $76.14 million versus the consensus estimate of $76.66 million.

"For the first quarter, we delivered solid revenue growth, improved utilization and strong profitability," commented Dr. Paul Johnston, President and CEO. "We are pleased that clients continued to call upon us to assist them with their most significant litigation matters and product recalls as well as to help them with risk management and new product development. We had notable performances from our material science, mechanical engineering, polymers science, human factors, structural engineering and construction consulting practices as well as in our environmental group.

"For the full year of 2015, we continue to expect growth in revenues before reimbursements to be in the low to mid-single digits and the EBITDA1 margin to be approximately flat with the 25% we achieved in 2014. Our underlying growth remains in the high single digits but will be partially offset by a significant decline in defense work and a major project stepping down in the second half of 2015.

"We remain focused on further expanding our unique market position in assessing the reliability, safety, human health and environmental issues of increasingly complex technologies, products, and processes," concluded Dr. Johnston.

For earnings history and earnings-related data on Exponent, Inc. (EXPO) click here.